Fusion Pharmaceuticals
(NASDAQ) FUSN
Fusion Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$35.68M
Net Income (TTM)
$104.28M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
FUSN News
FUSN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Fusion Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
113
CEO
John Valliant, PhD
Website
www.fusionpharma.comHeadquarters
Hamilton, ON L8P 0A6, CA
FUSN Financials
Key Financial Metrics (TTM)
Gross Margin
35%
Operating Margin
-48%
Net Income Margin
-46%
Return on Equity
-49%
Return on Capital
-37%
Return on Assets
-33%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$723.00K
Operating Income
$99.23M
EBITDA
$87.60M
Operating Cash Flow
$81.80M
Capital Expenditure
$3.89M
Free Cash Flow
$85.69M
Cash & ST Invst.
$234.08M
Total Debt
$50.33M
Fusion Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$361.00K
+97.7%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
101
N/A
Net Income
$33.67M
-38.6%
EBITDA
$31.69M
-48.8%
Quarterly Fundamentals
Net Cash
$146.45M
-14.4%
Accounts Receivable
$4.68M
+84.2%
Inventory
$0.00
+100.0%
Long Term Debt
$49.69M
+9.4%
Short Term Debt
$4.29M
-7.5%
Return on Assets
-33.20%
N/A
Return on Invested Capital
-36.80%
N/A
Free Cash Flow
$28.64M
-7.4%
Operating Cash Flow
$27.31M
-7.4%